Business · 13/02/1996Updated: 10/18/2026 · 1 min read
Reed & Carnrick Pharmaceuticals, et al.; Withdrawal of FDA Approval for 2 New Drug Applications and 67 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval for 2 new drug applications and 67 abbreviated new drug applications following written notifications from the applicants that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →